Largest health care companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 170 health care companies ranked by earnings, at SEK 272.7B, ahead of Eli Lilly (SEK 210B) and Merck & Co (SEK 185.7B). Figures as of 19 Nov 2026, 15:48 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Johnson & JohnsonSEK 272.7B
- Median
- SEK 2.8B
- Combined market value
- SEK 90.82T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Hims & Hers HealthHIMS · Health Care | SEK 1.3B | SEK 39.2B | SEK 167.07 | 3.70% down | 49% down | ||
| 102 | Ligand PharmaceuticalsLGND · Health Care | SEK 1.3B | SEK 59.4B | SEK 2,969.64 | 2.29% down | 50% up | ||
| 103 | Corcept TherapeuticsCORT · Health Care | SEK 1B | SEK 72.6B | SEK 663.69 | 3.78% down | 10% down | ||
| 104 | HaemoneticsHAE · Health Care | SEK 990.1M | SEK 55.9B | SEK 1,227.35 | 1.82% down | 64% up | ||
| 105 | Amneal PharmaceuticalsAMRX · Health Care | SEK 733.1M | SEK 76.1B | SEK 218.35 | 1.92% down | 90% up | ||
| 106 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 600.3M | SEK 75.4B | SEK 959.87 | 0.75% down | 129% up | ||
| 107 | RepligenRGEN · Health Care | SEK 497.5M | SEK 114.5B | SEK 1,791.94 | 2.00% up | 12% up | ||
| 108 | LifeStance Health GroupLFST · Health Care | SEK 98.3M | SEK 51.7B | SEK 136.08 | 2.87% down | 123% up | ||
| 109 | BillionToOneBLLN · Health Care | SEK 75.8M | SEK 44B | SEK 922.02 | 1.01% down | 4% down | ||
| 110 | Arrowhead PharmaceuticalsARWR · Health Care | -SEK 16.6M | SEK 62.8B | SEK 444.42 | 1.32% up | 13% up | ||
| 111 | BrukerBRKR · Health Care | -SEK 87.5M | SEK 100.4B | SEK 657.48 | 2.15% up | 44% up | ||
| 112 | RadNetRDNT · Health Care | -SEK 189.8M | SEK 56.2B | SEK 713.13 | 2.41% down | 9% down | ||
| 113 | Mirum PharmaceuticalsMIRM · Health Care | -SEK 237.7M | SEK 62.3B | SEK 954.73 | 1.45% up | 34% up | ||
| 114 | Travere TherapeuticsTVTX · Health Care | -SEK 259.9M | SEK 48.5B | SEK 505.22 | 1.16% down | 45% up | ||
| 115 | 10x GenomicsTXG · Health Care | -SEK 443M | SEK 80B | SEK 608.31 | 4.76% up | 247% up | ||
| 116 | Adaptive BiotechnologiesADPT · Health Care | -SEK 605.4M | SEK 47.4B | SEK 292.93 | 1.16% up | 74% up | ||
| 117 | Caris Life SciencesCAI · Health Care | -SEK 692.8M | SEK 57.1B | SEK 198.96 | 0.28% up | 19% down | ||
| 118 | VeradermicsMANE · Health Care | -SEK 712.2M | SEK 53.3B | SEK 1,264.24 | 0.48% down | 231% up | ||
| 119 | Belite BioBLTE · Health Care | -SEK 789.7M | SEK 63.1B | SEK 1,553.86 | 2.25% down | 43% up | ||
| 120 | Twist BioscienceTWST · Health Care | -SEK 790.3M | SEK 82.8B | SEK 1,214.64 | 2.60% up | 346% up | ||
| 121 | Oruka TherapeuticsORKA · Health Care | -SEK 1.1B | SEK 67.6B | SEK 996.34 | 2.28% up | 255% up | ||
| 122 | HeartflowHTFL · Health Care | -SEK 1.2B | SEK 40.2B | SEK 457.96 | 1.92% down | 66% up | ||
| 123 | ErascaERAS · Health Care | -SEK 1.3B | SEK 49.6B | SEK 141.27 | 0.91% up | 395% up | ||
| 124 | Protagonist TherapeuticsPTGX · Health Care | -SEK 1.3B | SEK 84.2B | SEK 1,290.54 | 0.25% down | 51% up | ||
| 125 | Charles River Laboratories InternationalCRL · Health Care | -SEK 1.5B | SEK 164B | SEK 3,422.82 | 0.95% up | 106% up | ||
| 126 | Spyre TherapeuticsSYRE · Health Care | -SEK 1.6B | SEK 95.4B | SEK 1,004.33 | 2.71% down | 332% up | ||
| 127 | CG OncologyCGON · Health Care | -SEK 1.6B | SEK 74.1B | SEK 829.33 | 1.89% up | 97% up | ||
| 128 | Dianthus TherapeuticsDNTH · Health Care | -SEK 1.7B | SEK 48.6B | SEK 863.92 | 1.11% up | 108% up | ||
| 129 | Edgewise TherapeuticsEWTX · Health Care | -SEK 1.7B | SEK 45.1B | SEK 411.56 | 2.22% down | 86% up | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | -SEK 1.9B | SEK 71.6B | SEK 1,361.25 | 0.16% down | 6% down | ||
| 131 | Definium TherapeuticsDFTX · Health Care | -SEK 1.9B | SEK 39.6B | SEK 289.36 | 2.34% down | 168% up | ||
| 132 | GlaukosGKOS · Health Care | -SEK 1.9B | SEK 141.8B | SEK 2,395.19 | 1.00% up | 145% up | ||
| 133 | Rhythm PharmaceuticalsRYTM · Health Care | -SEK 2B | SEK 82.6B | SEK 1,191.64 | 1.61% down | 18% up | ||
| 134 | NateraNTRA · Health Care | -SEK 2.1B | SEK 440.1B | SEK 3,035.12 | 3.04% up | 28% up | ||
| 135 | Kodiak SciencesKOD · Health Care | -SEK 2.3B | SEK 64.2B | SEK 981.54 | 1.37% down | 399% up | ||
| 136 | Elanco Animal HealthELAN · Health Care | -SEK 2.4B | SEK 135.9B | SEK 271.86 | 0.07% up | 26% up | ||
| 137 | LivaNovaLIVN · Health Care | -SEK 2.5B | SEK 51.7B | SEK 939.11 | 2.37% down | 77% up | ||
| 138 | Ascendis PharmaASND · Health Care | -SEK 2.6B | SEK 177.5B | SEK 2,705.56 | 1.63% down | 29% up | ||
| 139 | Madrigal PharmaceuticalsMDGL · Health Care | -SEK 2.9B | SEK 93.9B | SEK 4,041.23 | 0.22% down | 27% down | ||
| 140 | Legend BiotechLEGN · Health Care | -SEK 3B | SEK 31.3B | SEK 161.57 | 2.28% down | 41% down | ||
| 141 | Roivant SciencesROIV · Health Care | -SEK 3.1B | SEK 289.4B | SEK 399.45 | 1.37% up | 91% up | ||
| 142 | Praxis Precision MedicinesPRAX · Health Care | -SEK 3.1B | SEK 90B | SEK 3,218.41 | 3.65% up | 86% up | ||
| 143 | Kymera TherapeuticsKYMR · Health Care | -SEK 3.2B | SEK 103.3B | SEK 1,209.65 | 1.85% down | 87% up | ||
| 144 | Cogent BiosciencesCOGT · Health Care | -SEK 3.3B | SEK 49.1B | SEK 282.24 | 0.25% down | 20% down | ||
| 145 | MiniMed GroupMMED · Health Care | -SEK 3.4B | SEK 46.4B | SEK 165.08 | 4.50% down | 8% down | ||
| 146 | ImmunityBioIBRX · Health Care | -SEK 3.6B | SEK 70.1B | SEK 65.93 | 3.28% down | 232% up | ||
| 147 | Jazz PharmaceuticalsJAZZ · Health Care | -SEK 3.6B | SEK 156.7B | SEK 2,441.74 | 3.14% down | 41% up | ||
| 148 | Bausch + LombBLCO · Health Care | -SEK 3.7B | SEK 75.7B | SEK 211.63 | 0.72% down | 44% up | ||
| 149 | ABIVAXABVX · Health Care | -SEK 3.8B | SEK 75.3B | SEK 860.00 | 0.83% up | 32% down | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | -SEK 3.8B | SEK 61B | SEK 500.28 | 2.44% up | 26% up | ||
| 151 | Ionis PharmaceuticalsIONS · Health Care | -SEK 3.9B | SEK 45.8B | SEK 275.27 | 1.22% down | 63% down | ||
| 152 | GRAILGRAL · Health Care | -SEK 4.2B | SEK 49.7B | SEK 1,104.85 | 6.36% up | 19% up | ||
| 153 | Guardant HealthGH · Health Care | -SEK 4.2B | SEK 208.7B | SEK 1,542.92 | 4.48% up | 45% up | ||
| 154 | Oscar HealthOSCR · Health Care | -SEK 4.5B | SEK 83.6B | SEK 269.22 | 4.03% down | 112% up | ||
| 155 | ImmunovantIMVT · Health Care | -SEK 5.1B | SEK 69.1B | SEK 334.03 | 1.03% down | 46% up | ||
| 156 | AvantorAVTR · Health Care | -SEK 5.4B | SEK 105.7B | SEK 155.92 | 0.29% down | 40% up | ||
| 157 | CRISPR TherapeuticsCRSP · Health Care | -SEK 5.9B | SEK 39.8B | SEK 410.54 | 0.40% up | 18% down | ||
| 158 | BridgeBio PharmaBBIO · Health Care | -SEK 7.5B | SEK 156B | SEK 800.63 | 0.87% up | 21% up | ||
| 159 | VaxcytePCVX · Health Care | -SEK 7.8B | SEK 95B | SEK 600.04 | 0.78% up | 23% up | ||
| 160 | CytokineticsCYTK · Health Care | -SEK 8B | SEK 72.2B | SEK 518.55 | 0.69% down | 19% down | ||
| 161 | TeleflexTFX · Health Care | -SEK 9.2B | SEK 66.4B | SEK 1,674.65 | 0.76% down | 58% up | ||
| 162 | Takeda PharmaceuticalTAK · Health Care | -SEK 9.7B | SEK 695B | SEK 217.53 | 0.52% up | 51% up | ||
| 163 | Baxter InternationalBAX · Health Care | -SEK 9.7B | SEK 134.3B | SEK 259.55 | 2.48% down | 50% up | ||
| 164 | Summit TherapeuticsSMMT · Health Care | -SEK 11B | SEK 85.8B | SEK 107.24 | 0.38% up | 36% down | ||
| 165 | Revolution MedicinesRVMD · Health Care | -SEK 11.5B | SEK 358.2B | SEK 1,656.01 | 1.84% up | 129% up | ||
| 166 | BioNTechBNTX · Health Care | -SEK 12.8B | SEK 206.8B | SEK 834.11 | 1.54% down | 14% down | ||
| 167 | InsmedINSM · Health Care | -SEK 13B | SEK 309.7B | SEK 1,411.56 | 15.81% up | 40% down | ||
| 168 | ModernaMRNA · Health Care | -SEK 28.7B | SEK 801.9B | SEK 1,981.75 | 1.02% down | 780% up | ||
| 169 | ViatrisVTRS · Health Care | -SEK 35.8B | SEK 232.5B | SEK 202.78 | 1.73% down | 99% up | ||
| 170 | CenteneCNC · Health Care | -SEK 67.9B | SEK 323.3B | SEK 652.95 | 4.86% down | 94% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1745 SEK).
Questions and answers
Which health care companies rank first by earnings?
Johnson & Johnson (SEK 272.7B), Eli Lilly (SEK 210B) and Merck & Co (SEK 185.7B) are the top three of the 170 health care companies ranked by earnings as of 19 Nov 2026, 15:48 UTC.
How many health care companies are in this ranking?
170 are ranked by earnings.
What are these health care companies worth together?
The 170 health care companies ranked by earnings have a combined market value of SEK 90.82T as of 19 Nov 2026, 15:48 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.